Intellectual Property Contracts & Agreements
10,173 Contracts & Agreements
Intellectual property agreements include contracts relating to copyrights, trademarks, patents, and other inventions.
Browse by Subcategory
- License Agreements (9,581 contracts from 2,768 companies)
- Trademark Agreements (591 | 364)
- Aerospace & Defense (25 contracts from 9 companies)
- Air Freight & Logistics (7 | 3)
- Airlines (4 | 2)
- Auto Components (11 | 10)
- Automobiles (11 | 7)
- Banks (10 | 8)
- Beverages (18 | 6)
- Biotechnology (2,956 | 522)
- Building Products (14 | 9)
- Capital Markets (202 | 26)
- Chemicals (84 | 26)
- Commercial Services & Supplies (43 | 19)
- Communications Equipment (28 | 16)
- Construction & Engineering (7 | 2)
- Construction Materials (1 | 1)
- Consumer Finance (9 | 6)
- Containers & Packaging (7 | 2)
- Distributors (3 | 2)
- Diversified Consumer Services (24 | 6)
- Diversified Financial Services (9 | 7)
- Diversified Telecommunication Services (8 | 6)
- Electric Utilities (10 | 5)
- Electrical Equipment (49 | 16)
- Electronic Equipment, Instruments & Components (45 | 21)
- Energy Equipment & Services (82 | 43)
- Entertainment (73 | 15)
- Equity Real Estate Investment Trusts (REITs) (32 | 15)
- ETFs (88 | 50)
- Food Products (53 | 23)
- Food & Staples Retailing (6 | 4)
- Gas Utilities (1 | 1)
- Health Care Equipment & Supplies (657 | 180)
- Health Care Providers & Services (222 | 82)
- Health Care Technology (32 | 16)
- Hotels, Restaurants & Leisure (90 | 38)
- Household Durables (40 | 14)
- Household Products (3 | 2)
- Independent Power & Renewable Electricity Producers (3 | 2)
- Industrial Conglomerates (6 | 2)
- Insurance (18 | 14)
- Interactive Media & Services (28 | 17)
- Internet & Direct Marketing Retail (19 | 12)
- IT Services (40 | 16)
- Leisure Products (17 | 11)
- Life Sciences Tools & Services (168 | 28)
- Machinery (22 | 15)
- Media (73 | 18)
- Metals & Mining (50 | 18)
- Mortgage REITs, Lenders, & Securities (11 | 8)
- Multiline Retail (1 | 1)
- Oil, Gas & Consumable Fuels (96 | 37)
- Paper & Forest Products (5 | 1)
- Personal Products (68 | 28)
- Pharmaceuticals (1,253 | 279)
- Professional Services (17 | 10)
- Real Estate Management & Development (5 | 4)
- Road & Rail (2 | 2)
- Semiconductors & Semiconductor Equipment (94 | 34)
- Software (205 | 62)
- SPACs, Investment, & Acquisition Companies (138 | 56)
- Specialty Retail (28 | 14)
- Technology Hardware, Storage & Peripherals (27 | 11)
- Textiles, Apparel & Luxury Goods (54 | 13)
- Thrifts & Mortgage Finance (3 | 1)
- Tobacco (8 | 2)
- Trading Companies & Distributors (4 | 3)
- Transportation Infrastructure (1 | 1)
- Water Utilities (4 | 3)
- Wireless Telecommunication Services (10 | 4)
- Unassigned Industry (2,730 | 1,062)
- Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on December 23, 2024)
- Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on December 23, 2024)
- LICENSE AGREEMENT by and between Shanghai Jemincare Pharmaceutical Co., Ltd. and RAPT Therapeutics, Inc. dated as of December 22, 2024 (RAPT Therapeutics, Inc., Filed With SEC on December 23, 2024)
- Exclusive License Agreement by and between the StemMed, Ltd. and Baylor College of Medicine, dated June 19, 2015, subject to Notice of Assignment from Stem Med Limited Partnership... (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
- Exclusive License Agreement by and between the StemMed, Ltd. (f/k/a Stem Med Limited Partnership) and Baylor College of Medicine, dated July 16, 2012, as amended April 26, 2015,... (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
- Amendment #1 to License Agreement by and between the Company and Akebia Therapeutics, Inc. dated December 13, 2024 (Cyclerion Therapeutics, Inc., Filed With SEC on December 17, 2024)
- Amendment to License Agreement between the BC Cancer Agency, UBC and the Company, dated May 25, 2021 (Schedules have been omitted pursuant to Item 601(b)(10) of Regulation S-K.... (ESSA Pharma Inc., Filed With SEC on December 17, 2024)
- License Agreement, dated December 20, 2023 between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd, University of Rijeka Faculty of Medicine, and... (INVO Bioscience, Inc., Filed With SEC on December 17, 2024)
- License Agreement, dated December 19, 2023, between Inserm Transfert, Cytovia Therapeutics, Inc., and NAYA Therapeutics, Inc (fka NAYA Biosciences, Inc (INVO Bioscience, Inc., Filed With SEC on December 17, 2024)
- License & Management Agreement, dated December 14, 2024, by and between (Mountain Crest Acquisition Corp., Filed With SEC on December 16, 2024)
- License Agreement, dated as of April 8, 2021, by and between Kalaris Therapeutics, Inc. (formerly Theia Therapeutics, Inc.) and the Regents of the University of California, as... (Allovir, Inc., Filed With SEC on December 9, 2024)
- Form of Exclusive Source Code License agreement (True Nature Holding, Inc., Filed With SEC on December 6, 2024)
- Amendment to Amended and Restated Distribution License and Marketing Services Agreement, dated September 30, 2024, by and between the 5&2 Studios, Inc. and Come and See... (Chosen, Inc., Filed With SEC on December 6, 2024)
- Extension letter, dated October 16, 2024, extending the term of the January 1, 2020, License Agreement among Tommy Hilfiger Licensing LLC, Movado Group, Inc. and Swissam Products... (Movado Group, Inc., Filed With SEC on December 5, 2024)
- First Amendment dated September 17, 2024, to the Amended and Restated License Agreement dated March 17, 2022, between the Company and HUGO BOSS AG Branch CH-Zug (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Fifth Amendment dated September 12, 2024, to the Amended and Restated License Agreement dated January 13, 2015, between the Company and Tapestry, Inc (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Fourth Amendment dated August 31, 2023, to the Amended and Restated License Agreement dated January 13, 2015, between the Company and Tapestry, Inc (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Third Amendment dated February 2, 2023, to the Amended and Restated License Agreement dated January 13, 2015, between the Company and Tapestry, Inc (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Brand License Agreement, dated as of December 2, 2024, by and between TechTarget, Inc. (formerly known as Toro CombineCo, Inc.) and Informa Group Limited (Toro CombineCo, Inc., Filed With SEC on December 3, 2024)
- Cell Line License Agreement, effective October 22, 2024, by and between WuXi Biologics Ireland Limited and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
- APRIL License Agreement, dated October 30, 2024, by and between Paragon Therapeutics, Inc. and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
- Amendment No. 1 to Second Amended and Restated Supply and License Agreement, dated March 5, 2024, between 4C Medical Technologies, Inc. and Anteris Technologies Corporation (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
- Second Amended and Restated Supply and License Agreement, dated June 1, 2018, between 4C Medical Technologies, Inc. and Admedus Corporation (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
- License Agreement, dated October 11, 2019, among Admedus Ltd, Admedus Regen Pty Ltd, Admedus Biomanufacturing Pty Ltd and LeMaitre Vascular, Inc (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
- Amendment to License Agreement with Monarch Media (Blue Line Holdings, Inc., Filed With SEC on November 19, 2024)
- License Agreement with Monarch Media, LLC (Blue Line Holdings, Inc., Filed With SEC on November 19, 2024)
- Amendment to License Agreement (Comstock Mining Inc., Filed With SEC on November 19, 2024)
- Nonexclusive License Agreement between Neurogene Inc. and the Board of Trustees of the Leland Stanford Junior University dated August 6, 2024 (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on November 18, 2024)
- Exclusive License Agreement, dated July 10, 2024, between Akos Biosciences, Inc. and Aries Science and Technology, LLC (AMERI Holdings, Inc., Filed With SEC on November 14, 2024)
- Fourth Amendment to Exclusive License Agreement (Sensitization of Solid Tumors), dated November 13, 2024, by and between Enviro Therapeutics Inc. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
- Third Amendment to Exclusive License Agreement (RelA of NF-kB), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
- Third Amendment to Exclusive License Agreement (Fibrosis), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
- Fourth Amendment to Exclusive License Agreement (Depletion of DNA), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center and Enviro... (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
- Third Amendment to Exclusive License Agreement (Cancer Autoimmune), dated November 13, 2024, by and between Kairos Pharma, Ltd. and Cedars-Sinai Medical Center (Kairos Pharma, LTD., Filed With SEC on November 14, 2024)
- Fifth Amendment to Data License Agreement dated September 26, 2024 (SURF AIR MOBILITY INC., Filed With SEC on November 14, 2024)
- Storage License Agreement by and among the Company, BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc., dated as of September 23, 2024 (Dynamics Special Purpose Corp., Filed With SEC on November 14, 2024)
- Amendment 4 to Exclusive License Agreement, dated October 28, 2024, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited (Spero Therapeutics, Inc., Filed With SEC on November 14, 2024)
- Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018 (DURECT CORP, Filed With SEC on November 14, 2024)
- Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015 (DURECT CORP, Filed With SEC on November 14, 2024)
- First Amendment to the License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Liquidia Corp, Filed With SEC on November 13, 2024)
